A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I - Concepedia

Concepedia

Publication | Open Access

A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I

DOI Full Paper Access

165

Citations

27

References

2003

Year

Henry Eriksson, Karin Wåhlander, David Gustafsson, Lennart Welin, Lars Frison, Sam Schulman

Journal of Thrombosis and Haemostasis

ThrombosisVenous ThrombosisCardiovascular DiseaseMedicineHematologyDose-guiding StudyPharmacotherapyPharmacologyAnticoagulantStandard Therapy

References

	Year	Citations

Page 1